BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23867693)

  • 1. Mucocutaneous leishmaniasis: mucosal manifestations in an endemic country.
    de Paulo LF; Rocha GF; Luisi CM; Rosa RR; Durighetto AF
    Int J Infect Dis; 2013 Nov; 17(11):e1088-9. PubMed ID: 23867693
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and Safety of Liposomal Amphotericin B for the Treatment of Mucosal Leishmaniasis from the New World: A Retrospective Study.
    Cunha MA; Leão AC; de Cassia Soler R; Lindoso JA
    Am J Trop Med Hyg; 2015 Dec; 93(6):1214-8. PubMed ID: 26483120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated oral mucosal leishmaniasis.
    Ahmed NH; Mukherjee A; Samantaray JC; Kar HK
    Indian J Dermatol Venereol Leprol; 2014; 80(4):343-5. PubMed ID: 25035365
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucocutaneous leishmaniasis: report of a case with massive involvement of nasal, pharyngeal and laryngeal mucosa.
    Di Lella F; Vincenti V; Zennaro D; Afeltra A; Baldi A; Giordano D; Pasanisi E; Bacciu A; Bacciu S; Di Lella G
    Int J Oral Maxillofac Surg; 2006 Sep; 35(9):870-2. PubMed ID: 16574379
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomal formulation of amphotericin B for the treatment of mucosal leishmaniasis in HIV-negative patients.
    Rocio C; Amato VS; Camargo RA; Tuon FF; Nicodemo AC
    Trans R Soc Trop Med Hyg; 2014 Mar; 108(3):176-8. PubMed ID: 24535153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prolonged incubation period in zosteriform Leishmania panamensis.
    Gogol-Tagliaferro A; Swender D; Chernin L; Tcheurekdjian H; Meyerson H; Hostoffer R
    Cutis; 2014 Feb; 93(2):E5-6. PubMed ID: 24605357
    [No Abstract]   [Full Text] [Related]  

  • 7. First molecular-based detection of mucocutaneous leishmaniasis caused by Leishmania major in Iran.
    Alborzi A; Pouladfar GR; Ghadimi Moghadam A; Attar A; Drakhshan N; Khosravi Maharlooei M; Kalantari M
    J Infect Dev Ctries; 2013 May; 7(5):413-6. PubMed ID: 23669431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches.
    Cruz AF; Resende RG; Albuquerque DR; de Lacerda JC; Leite CF; Ferreira Aguiar MC
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2016 Dec; 122(6):e199-e203. PubMed ID: 27234853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary oral leishmaniasis mimicking oral cancer: a case report.
    Celentano A; Ruoppo E; Mansueto G; Mignogna MD
    Br J Oral Maxillofac Surg; 2015 Apr; 53(4):396-8. PubMed ID: 25701438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal Leishmania infantum infection.
    Richter J; Hanus I; Häussinger D; Löscher T; Harms G
    Parasitol Res; 2011 Sep; 109(3):959-62. PubMed ID: 21499751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports.
    Crovetto-Martínez R; Aguirre-Urizar JM; Orte-Aldea C; Araluce-Iturbe I; Whyte-Orozco J; Crovetto-De la Torre MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jan; 119(1):e20-6. PubMed ID: 25442251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A patient with chronic labial oedema and nodular palatal lesions.
    Gonzalez-Olivares M; Moreno-Torres A; Navarro-Vidal B; Cordoba S; Garrido-Rios AA; Ruiz-Giardin JM; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):481-484. PubMed ID: 29344972
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucocutaneous leishmaniasis treated with liposomal amphotericin B.
    Lambertucci JR; Silva LC
    Rev Soc Bras Med Trop; 2008; 41(1):87-8. PubMed ID: 18368279
    [No Abstract]   [Full Text] [Related]  

  • 14. Liposomal amphotericin B treatment of Old World cutaneous and mucosal leishmaniasis: A literature review.
    Mosimann V; Neumayr A; Paris DH; Blum J
    Acta Trop; 2018 Jun; 182():246-250. PubMed ID: 29550282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome.
    Nonata R; Sampaio R; Marsden PD
    Trans R Soc Trop Med Hyg; 1997; 91(1):77. PubMed ID: 9093636
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of mucosal leishmaniasis (L. infantum) with miltefosine in a patient with Good syndrome.
    Stoeckle M; Holbro A; Arnold A; Neumayr A; Weisser M; Blum J
    Acta Trop; 2013 Oct; 128(1):168-70. PubMed ID: 23871798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case.
    Oyama J; Ferreira FBP; Conter CC; Lera-Nonose DSSL; Ramos-Milaré ÁCFH; Venazzi EAS; Silveira TGV; Lonardoni MVC
    Rev Inst Med Trop Sao Paulo; 2018; 60():e3. PubMed ID: 29451600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmaniasis of the tongue in a renal transplant recipient.
    Alrajhi AA; Saleem M; Ibrahim EA; Gramiccia M
    Clin Infect Dis; 1998 Nov; 27(5):1332-3. PubMed ID: 9827301
    [No Abstract]   [Full Text] [Related]  

  • 19. A case of mucocutaneous leishmaniasis.
    Virgilio GR; Hale BR
    Otolaryngol Head Neck Surg; 2005 May; 132(5):800-1. PubMed ID: 15886638
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical mucocutaneous involvement with Leishmania donovani.
    Pulimood SA; Rupali P; Ajjampur SS; Thomas M; Mehrotra S; Sundar S
    Natl Med J India; 2012; 25(3):148-50. PubMed ID: 22963292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.